Pascal Biosciences Pascal Biosciences is a preclinical-stage biotechnology company that focuses on diseases such as glioblastoma and other intractable cancers. | ![]() Curtana Pharmaceuticals Curtana Pharmaceuticals is a company specializing in therapies for brain cancer. | ![]() Immune Pharmaceuticals Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics. | Thermosome Thermosome is a biopharmaceutical company developing drug candidates by leveraging its proprietary drug delivery technology, which exploits a mechanism of action called intravascular drug release. | ||
Founding Date | Founding Date 2013 | Founding Date 2013 | Founding Date 2010 | Founding Date 2017 | Founding Date 2015 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Seattle, US HQ Vancouver, CA | Locations Austin, US HQ | Locations New York, US HQ Jerusalem, IL | Locations US HQ | Locations Planegg, DE HQ |
Employees | Employees 7 | Employees 7 | Employees 722% decrease | Employees 4 | Employees 9 |
Valuation ($) | Valuation ($) 729.5 k | Valuation ($) N/A | Valuation ($) 1.6 m | Valuation ($) N/A | Valuation ($) N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 3.2m (over 6 years ago) | Latest funding round $ 5.2m (about 10 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 11.7m | Total funding raised $ 3.2m | Total funding raised $ 5.2m |

Curtana Pharmaceuticals is a company specializing in therapies for brain cancer.
View company
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics.
View company
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
View companyThermosome is a biopharmaceutical company developing drug candidates by leveraging its proprietary drug delivery technology, which exploits a mechanism of action called intravascular drug release.
View company